~ 110907 Higher Vitamin D Levels Linked to Reduced Telomere Shortening
The November, 2007 issue of the American Journal of Clinical Nutrition published an article describing the discovery of British and American researchers of an association between longer telomeres and increased levels of vitamin D. Telomeres are caps on the ends of chromosomes which have been found to shorten with age, as well as with increased oxidative stress and inflammation. The finding suggests that vitamin D may play a role in slowing the onset of age-related diseases.
Dr J. Brent Richards at King's College, London School of Medicine and colleagues studied 2,160 female twins aged 19 to 79 for the current research. Blood samples were analyzed for serum vitamin D levels, C-reactive protein (CRP, a marker of inflammation) and additional factors, and telomere length was measured in the DNA of peripheral white blood cells (leukocytes).
As expected, older participants had shorter telomeres; however, leukocyte telomere length (LTL) was greater among subjects whose levels of vitamin D were high compared to those with low concentrations, a finding which persisted after adjustment for age and other factors. Participants in the top one-third of serum vitamin D levels had telomeres that averaged 107 base pairs longer than those in the lowest third, equivalent to a five year difference in chronologic aging.
Telomere length was also greater in those with lower C-reactive protein levels than in subjects with higher concentrations. When participants who had the highest CRP and lowest vitamin D concentrations were compared with those who had the lowest CRP and highest vitamin D levels, the difference in telomere length was equivalent to 7.6 years of aging.
In a subset analysis of vitamin D supplement users, those who supplemented were also found to have longer telomeres than those who did not supplement with the vitamin.
In their discussion concerning mechanisms of action, the authors note that inflammation and oxidative stress are key determinants in the biology of aging, and that vitamin D decreases mediators of systemic inflammation such as interleukin-2 and tumor necrosis factor-alpha. While habits that increase oxidative stress and inflammation may be difficult to change, they observe that â€śvitamin D concentrations are easily modifiable through nutritional supplementation or sunshine exposure.â€ť
"Although both LTL and serum vitamin D concentrations decrease with age and are thus possible markers of aging in general, we have shown that the positive association between LTL and vitamin D concentrations is independent of age and many other covariates," the authors conclude. "Longitudinal studies or randomized controlled trials of supplementation exploring the effect of vitamin D on LTL will be necessary to unequivocally establish the relation between vitamin D and leukocyte telomere dynamics; but for the moment, our data suggest another potential benefit of vitamin D--on the aging process and age-related disease."
Health Concern: Inflammation
While some doctors are finally catching on to the fact that elevated C-reactive protein increases heart attack and stroke risk, they still know little about its other dangers. Even fewer practicing physicians understand that pro-inflammatory cytokines are an underlying cause of systemic inflammation that is indicated by excess C-reactive protein in the blood.
It is well established the elevated C-reactive protein, IL-6 and other inflammatory cytokines indicate significantly greater risks of contracting or dying from specific diseases (heart attack, stroke, Alzheimer's disease, etc.).
A group of doctors wanted to ascertain if C-reactive protein and IL-6 could also predict the risks of all-cause mortality. In a study published in the American Journal of Medicine, a sample of 1,293 healthy elderly people were was followed for a period of 4.6 years (Harris et al. 1999). Higher IL-6 levels were associated with a twofold greater risk of death. Higher C-reactive protein was also associated with a greater risk of death, but to a lesser extent than elevated IL-6. Subjects with both high C-reactive protein and IL-6 were 2.6 times more likely to die during follow up than those with low levels of both of these measurements of inflammation.
FREE Shipping in the CONTINENTAL UNITED STATES - ALL ORDERS
The statements made here have not been evaluated by the FDA. The foregoing statements are based upon sound and reliable studies, and are meant for informational purposes. Consult with your medical practitioner to determine the underlying cause of your symptoms. Please always check your purchase for possible allergins and correct dosage on the bottle before use.
While we work to ensure that product information is correct, on occasion manufacturers may alter their ingredient lists. Actual product packaging and materials may contain more and/or different information than that shown on our Web site. We recommend that you do not solely rely on the information presented and that you always read labels, warnings, and directions before using or consuming a product. For additional information about a product, please contact the manufacturer. Content on this site is for reference purposes and is not intended to substitute for advice given by a physician, pharmacist, or other licensed health-care professional. You should not use this information as self-diagnosis or for treating a health problem or disease. Contact your health-care provider immediately if you suspect that you have a medical problem. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease or health condition. Life Extension Institute assumes no liability for inaccuracies or misstatements about products.